Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) is 34.20% higher on its value in year-to-date trading and has touched a low of $1.08 and a high of $19.30 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SONN stock was last observed hovering at around $9.64 in the last trading session, with the day’s gains setting it 0.13%.
Currently trading at $9.77, the stock is 202.66% and 381.78% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.62 million and changing 1.35% at the moment leaves the stock 315.93% off its SMA200. SONN registered 569.18% gain for a year compared to 6-month loss of 518.35%. The firm has a 50-day simple moving average (SMA 50) of $1.861 and a 200-day simple moving average (SMA200) of $2.3364.
The stock witnessed a 727.97% gain in the last 1 month and extending the period to 3 months gives it a 657.36%, and is 118.57% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 49.49% over the week and 31.50% over the month.
Sonnet BioTherapeutics Holdings Inc (SONN) has around 13 employees, a market worth around $30.93M and $1.00M in sales. Profit margin for the company is -1328.60%. Distance from 52-week low is 804.63% and -49.38% from its 52-week high. The company has generated returns on investments over the last 12 months (-2006.15%).
The EPS is expected to grow by 69.52% this year, but quarterly earnings will post 5,267.69% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Sonnet BioTherapeutics Holdings Inc (SONN) Top Institutional Holders
9.0 institutions hold shares in Sonnet BioTherapeutics Holdings Inc (SONN), with institutional investors hold 5.32% of the company’s shares. The shares outstanding are 3.17M, and float is at 3.13M with Short Float at 1.31%. Institutions hold 5.24% of the Float.
Sonnet BioTherapeutics Holdings Inc (SONN) Insider Activity
#####